Posts by Blue Horizon

BHI Therapeutic Sciences attended the World Economic Forum in Davos, Switzerland.

Posted by on Jun 5, 2018 in news | 0 comments

The 2018 World Economic Forum (WEF) in Davos explored the ideas, innovations and discoveries that are reshaping our world by working closely with those in the vanguard of change from such fields as the arts, culture, engineering, media, medicine, science, and technology. During the past few days, the US-based company BHI Therapeutic Sciences (BHITS) represented by Brian Mehling, MD, Founder and Chief Medical Officer; Klara Doert, President of International Business Development; Katarina Novakova, Director of Relations; and Manuel McDonald, International Consultant attended the annual meeting...

Read More

WORLD-RENOWNED STEM CELL RESEARCHER AND BOARD-CERTIFIED SURGEON, DR. BRIAN MEHLING, SET TO ATTEND THE 48TH ANNUAL WORLD ECONOMIC FORUM IN DAVOS

Posted by on Jun 5, 2018 in news | 0 comments

FOUNDER OF BLUE HORIZON INTERNATIONAL AVAILABLE TO DISCUSS BREAKTHROUGHS IN STEM CELL RESEARCH   ZURICH, Switzerland – January 18, 2017 – Dr. Brian Mehling, world-renowned stem cell researcher, board-certified orthopedic trauma surgeon, and founder of Blue Horizon International (BHI), will be attending The 48th Annual World Economic Forum (WEF) in DAVOS from January 23-26. This will be Dr. Mehling’s sixth year attending the global conference.   The theme of this year’s forum is “Creating a Shared Future in a Fractured World” and discussions will centralize around how...

Read More

Brian Mehling, M.D. and Blue Horizon International team to attend 3 Day Masterclass in Clinical Trials in New York

Posted by on Jun 27, 2017 in news | 0 comments

The 3 day long Masterclass in Clinical Trials and Medicine Development is organized by Terrapinn Ltd and will be held during February 22 – 24, 2017 in New York, NY.   The Masterclass in Clinical Trials is designed to provide insight into new business opportunities in the field of clinical trials and the development process of new healthcare interventions. The course will provide insight into complex cross-disciplinary integrated health within the process of diffusion of new medical interventions, from pharmaceuticals, medical devices, diagnostics, surgical interventions to dietary...

Read More

Blue Horizon International making a splash at film festivals worldwide

Posted by on Jun 27, 2017 in news | 0 comments

Brian Mehling, M.D. and Blue Horizon International (BHI) have recently been making headlines – from being featured in VOGUE magazine, news of the preview screening of their stem cell documentary “Stem Cells – The Next Frontier,” which was screened during the Tribeca Film Festival in April, to its screening at the Cannes Film Festival on May 25th. There was also a well-attended networking event that followed the next day to celebrate the successful screening in Cannes. “Stem Cells – The Next Frontier” is a documentary about stem cell research being the next frontier in medicine,...

Read More

Blue Horizon International team to attend Clinical Trials Masterclass in New York

Posted by on Feb 20, 2017 in news | 0 comments

Blue Horizon International team to attend Clinical Trials Masterclass in New York   Brian Mehling, M.D. and Marina Manvelyan, Ph.D., will attend a three-day long Masterclass in Clinical Trials and Medicine Development from February 22 – 24, 2017 in New York, NY.   The Masterclass in Clinical Trials is designed to provide insight into new business opportunities in the field of clinical trials and the development process of new healthcare interventions. The course will provide insight into complex cross-disciplinary integrated health within the process of diffusion of new...

Read More